Home › Crohn's Disease › Texas › Lubbock

Pag-aaral pangklinika para sa Crohn's Disease sa Lubbock, TX

Isang pag-aaral para sa Crohn's Disease ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Lubbock. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

Nagre-recruitPhase 4

West Texas Research Institute, Lubbock

Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 30, 2026 · NCT06581328

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

Nagre-recruitPhase 3

Caprock Gastro Research ( Site 5077), Lubbock

Edad 16 hanggang 80 · Lahat ng kasarian · Na-update Set 29, 2026 · NCT06430801

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

Nagre-recruitPhase 2

GI Alliance - Lubbock /ID# 283920, Lubbock
Caprock Gastro Research - Lubbock /ID# 283921, Lubbock

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07697456

A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

Nagre-recruitPhase 3

Lubbock Gastroenterology, Lubbock

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07499232

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

Nagre-recruitPhase 2

Caprock Gastro Research - Lubbock /ID# 265541, Lubbock

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06548542

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Nagre-recruitPhase 3

GI Alliance - Lubbock-Site Number: 8400092, Lubbock

Edad 16 hanggang 80 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07184931

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Nagre-recruitPhase 3

GI Alliance - Lubbock-Site Number: 8400092, Lubbock

Edad 16 hanggang 80 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07184944

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

Nagre-recruitPhase 4

Texas Digestive Disease Consultants Lubbock, Lubbock

Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 9, 2026 · NCT06045754

Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

Nagre-recruitPhase 3

GI Alliance - Lubbock ( Site 0288), Lubbock
Caprock Gastro Research ( Site 0293), Lubbock

Lahat ng edad · Lahat ng kasarian · Na-update Set 9, 2026 · NCT06651281

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

Nagre-recruitPhase 2

Mirador Therapeutics Selected Site, Lubbock

Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Mar 12, 2026 · NCT07113522

Pag-aaral para sa Crohn's Disease sa ibang lungsod

Iba pang pag-aaral sa Lubbock

Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.